The notices it replaced
- Reissues: PAR-24-162 Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
- 2 steps back: PAR-21-062 Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
- 3 steps back: PA-18-615 Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,624,307 in first-year total cost, median $256,932.
Most frequent study sections
- HIV Comorbidities and Clinical Studies Study Section[HCCS]4
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]1
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- EMORY UNIVERSITY1
- HENRY M. JACKSON FDN FOR THE ADV MIL/MED1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF COLORADO DENVER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Investigation of the Role of MicroRNAs in Adipose Tissue from People Infected with HIV Who Develop Type 2 Diabetes1R21DK145238-01 · under PAR-24-162 | FLOWERS, ELENA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $451,000 | HCCS |
| 2025 | Utilizing the ex vivo rectal explant challenge model to evaluate HIV-1 Transmitted/Founder replication and inflammation within human gut mucosal tissue1R21DK142595-01A1 · under PAR-24-162 | SMITH, STACEY ABIGAIL | EMORY UNIVERSITY, GA | $430,375 | HIVD |
| 2024 | Effect of Ubiquitin D variants upon APOL1-mediated kidney injury1R21DK138863-01A1 · under PAR-21-062 | ROSS, MICHAEL J | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $252,000 | HCCS |
| 2024 | Effect of ILC3 loss on epithelial barrier function during ART Treated HIV infection1R21DK138855-01A1 · under PAR-21-062 | NEFF, CHARLES PRESTON | UNIVERSITY OF COLORADO DENVER, CO | $234,000 | HCCS |
| 2022 | Impact of Microbial Dysbiosis on MAIT Cell Tissue Repair Program after Acute HIV Infection1R21DK132985-01 · under PAR-21-062 | CORLEY, MICHAEL JAYPAQUIN-PROULX, DOMINIC | HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD | $256,932 | HCCS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.